( August 14, 2025, 2:33 PM EDT) -- WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel on Aug. 13 reversed a Delaware federal jury’s finding that a genetic sequencing kit-maker infringed a competitor’s patents and owed $4.7 million in damages; the panel held that no reasonable jury could have found that the accused product met multiple specifications of the patents at issue....